CRLComplete Response Letter
Complete Response Letter Ocular Therapeutix, Inc. (Jul 21, 2016)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Chemistry, manufacturing, and controls, Facility inspection and CGMP compliance. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• DEXTENZA
